Home › NDC Lookup › RxCUI directory › RxCUI 749858

{21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1... — RxCUI 749858

RxNorm drug concept · Generic pack
RxCUI 749858 Generic pack · GPCK ● Current RxNorm concept 10 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI749858
Official name{21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asEth estra-Noreth 0.035-1 MG (21) Oral Tablet / Inert 1 MG (7) Oral Tablet 28 Day Pack
FDA products mapped10
Package NDCs mapped14
Reported Medicaid activity (SDUD)76,233 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Norethindrone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Most norethindrone tablets — including brands like Camila, Errin, Emzahh, and Affodel — are progestin-only birth control pills taken daily to prevent pre...
  • Regular combination birth control pills contain two hormones — estrogen and progestin. Norethindrone is a progestin-only pill, sometimes called the 'mini-pill.' Because it has no e...
  • How is this different from regular birth control pills?
  • The most common thing people notice is irregular bleeding — spotting between periods, or changes in your cycle. Headache, breast tenderness, nausea, and dizziness are also reported...
📖 Read our full Norethindrone guide →

🕸️ Concept Web — How {21 (ethinyl estradiol 0.035 MG / norethindrone... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack RxCUI 749858

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Inert ingredients 748794
    • Norethindrone 7514
    • Ethinyl estradiol / norethindrone 384410
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / norethindrone Oral Tablet 372105
    • Inert ingredients Oral Tablet 748796
    • Ethinyl estradiol / norethindrone Oral Product 1157354
    • Ethinyl estradiol / norethindrone Pill 1157355
    • Inert ingredients Oral Product 1156911
    • Inert ingredients Pill 1156912
    • Pack 746839
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  4. Packs 7

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 24 of 25 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet SCD · 312033
  • Inert ingredients 1 MG Oral Tablet SCD · 748797
  • Ethinyl estradiol 0.035 MG SCDC · 317633
  • Inert ingredients 1 MG SCDC · 748795
  • Norethindrone 1 MG SCDC · 316386
  • Ethinyl estradiol / norethindrone Oral Tablet SCDF · 372105
  • Inert ingredients Oral Tablet SCDF · 748796
  • Ethinyl estradiol / norethindrone Oral Product SCDG · 1157354
  • Ethinyl estradiol / norethindrone Pill SCDG · 1157355
  • Inert ingredients Oral Product SCDG · 1156911

Brand-Name Concepts

📦 FDA Products & Package NDCs

10 products · 14 package NDCs
14 package NDCs map to RxCUI 749858 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00555-9008-67 3 POUCH in 1 CARTON (0555-9008-67) / 1 BLISTER PACK in 1 PO... Nortrel 28 Day Teva Pharmaceuticals USA, Inc. 2001-06-06
00555-9009-42 3 POUCH in 1 CARTON (0555-9009-42) / 1 BLISTER PACK in 1 PO... Nortrel 21 Day Teva Pharmaceuticals USA, Inc. 2001-06-13
00555-9010-58 6 POUCH in 1 CARTON (0555-9010-58) / 1 BLISTER PACK in 1 PO... Nortrel 28 Day Teva Pharmaceuticals USA, Inc. 2001-06-06
16714-0348-01 1 BLISTER PACK in 1 PACKET (16714-348-01) / 1 KIT in 1 BLIS... Dasetta 1/35 Northstar Rx LLC 2011-12-22
16714-0348-02 1 BLISTER PACK in 1 CARTON (16714-348-02) / 1 KIT in 1 BLIS... Dasetta 1/35 Northstar Rx LLC 2011-12-22
16714-0348-03 3 BLISTER PACK in 1 CARTON (16714-348-03) / 1 KIT in 1 BLIS... Dasetta 1/35 Northstar Rx LLC 2011-12-22
16714-0348-04 6 BLISTER PACK in 1 CARTON (16714-348-04) / 1 KIT in 1 BLIS... Dasetta 1/35 Northstar Rx LLC 2011-12-22
50090-1477-00 1 KIT in 1 KIT (50090-1477-0) ALYACEN 1/35 A-S Medication Solutions 2014-11-28
65862-0898-88 3 POUCH in 1 CARTON (65862-898-88) / 1 BLISTER PACK in 1 PO... Nylia 1/35 Aurobindo Pharma Limited 2016-10-21
65862-0898-92 6 POUCH in 1 CARTON (65862-898-92) / 1 BLISTER PACK in 1 PO... Nylia 1/35 Aurobindo Pharma Limited 2016-10-21
68462-0394-29 3 BLISTER PACK in 1 CARTON (68462-394-29) / 1 KIT in 1 BLIS... ALYACEN 1/35 Glenmark Pharmaceuticals Inc., USA 2012-01-19
68462-0556-29 3 BLISTER PACK in 1 CARTON (68462-556-29) / 1 KIT in 1 BLIS... ALYACEN 7/7/7 Glenmark Pharmaceuticals Inc., USA 2012-01-19
71205-0547-28 1 PACKAGE in 1 BAG (71205-547-28) / 1 KIT in 1 PACKAGE ALYACEN 1/35 Proficient Rx LP 2021-03-25
79929-0007-07 3 BLISTER PACK in 1 CARTON (79929-007-07) / 1 KIT in 1 BLIS... Norethindrone and ethinyl estradiol Naari Pte Limited 2022-12-31
Observed labelers: Northstar Rx LLC (4) · Teva Pharmaceuticals USA, Inc. (3) · Aurobindo Pharma Limited (2) · Glenmark Pharmaceuticals Inc., USA (2) · A-S Medication Solutions (1) · Naari Pte Limited (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.